Trades on 1 secondary market
Granata Bio
Granata Bio is a reproductive-health biopharmaceutical company founded in 2018 and headquartered in the United States, focused on expanding access to fertility and IVF therapeutics across North America. The company identifies, licenses, and develops biopharmaceuticals spanning the in-vitro fertiliza
Granata Bio is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.